Company profile VCEL

Vericel Corp
about vericel founded in 1989, vericel (formerly aastrom biosciences), is dedicated to the development of patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. the company markets two cell therapy products in the united states, carticel® (autologous cultured chondrocytes), an autologous chondrocyte implant for ...the treatment of cartilage defects in the knee and epicel® (cultured epidermal autografts), a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area. vericel is also developing maci, a third-generation autologous chondrocyte implant for the treatment of cartilage defects in the knee, and ixmyelocel-t, a patient specific multicellular therapy for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy (dcm). to fulfill vericel’s mission of helping people with severe diseases and conditions rea Show More
Quarter analysis & expected interestLast update: February 09 2024 11:26:46.

After 39 days of this quarter the interest is at 92.0. Based on that we can calculate that during remaining 52 days it will total up to 215.0.
Vericel expected interest is significantly lower compared to same quarter last year (-58.7%) but similar to previous quarter.

YearQ1Q2Q3Q4
2019376
545
44.9% QoQ
459
-15.8% QoQ
407
-11.3% QoQ
2020 402
6.9% YoY -1.2% QoQ
338
-38.0% YoY -15.9% QoQ
338
-26.4% YoY 0.0% QoQ
392
-3.7% YoY 16.0% QoQ
2021 528
31.3% YoY 34.7% QoQ
522
54.4% YoY -1.1% QoQ
349
3.3% YoY -33.1% QoQ
255
-34.9% YoY -26.9% QoQ
2022 424
-19.7% YoY 66.3% QoQ
421
-19.3% YoY -0.7% QoQ
462
32.4% YoY 9.7% QoQ
358
40.4% YoY -22.5% QoQ
2023 520
22.6% YoY 45.3% QoQ
285
-32.3% YoY -45.2% QoQ
449
-2.8% YoY 57.5% QoQ
228
-36.3% YoY -49.2% QoQ
2024 92
-82.3% YoY -59.6% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Vericel search interestLast update: February 09 2024 11:26:46.
Correlation coefficient between keyword and revenue is -0.66
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 11:26:49.

The average 5 years interest of Vericel was 31.23 per week.
The last year interest of Vericel compared to the last 5 years has changed by -18.89%.
The interest for Vericel is significantly decreasing.
The last year interest is quite lower compared to 5 years ago. It has decreased by -32.97%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 11:27:05.

After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0.
Vericel stock expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).

YearQ1Q2Q3Q4
2019190
206
8.4% QoQ
189
-8.3% QoQ
37
-80.4% QoQ
2020 142
-25.3% YoY 283.8% QoQ
219
6.3% YoY 54.2% QoQ
136
-28.0% YoY -37.9% QoQ
178
381.1% YoY 30.9% QoQ
2021 338
138.0% YoY 89.9% QoQ
231
5.5% YoY -31.7% QoQ
212
55.9% YoY -8.2% QoQ
117
-34.3% YoY -44.8% QoQ
2022 289
-14.5% YoY 147.0% QoQ
118
-48.9% YoY -59.2% QoQ
256
20.8% YoY 116.9% QoQ
215
83.8% YoY -16.0% QoQ
2023 130
-55.0% YoY -39.5% QoQ
63
-46.6% YoY -51.5% QoQ
155
-39.5% YoY 146.0% QoQ
75
-65.1% YoY -51.6% QoQ
2024 0
-100.0% YoY -100.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Vericel stock search interestLast update: February 09 2024 11:27:05.
Correlation coefficient between keyword and revenue is -0.1
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 11:27:12.

The average 5 years interest of Vericel stock was 13.39 per week.
The last year interest of Vericel stock compared to the last 5 years has changed by -52.43%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -46.74%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Vericel cell therapies to provide analysis

Correlation between past revenue and Vericel cell therapies search interest

There is not enough data for Vericel cell therapies to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Vericel cell therapies to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 11:27:20.

After 39 days of this quarter the interest is at 60.0. Based on that we can calculate that during remaining 52 days it will total up to 140.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
20190
0
76
inf% QoQ
123
61.8% QoQ
2020 83
inf% YoY -32.5% QoQ
36
inf% YoY -56.6% QoQ
103
35.5% YoY 186.1% QoQ
61
-50.4% YoY -40.8% QoQ
2021 89
7.2% YoY 45.9% QoQ
107
197.2% YoY 20.2% QoQ
115
11.7% YoY 7.5% QoQ
284
365.6% YoY 147.0% QoQ
2022 77
-13.5% YoY -72.9% QoQ
85
-20.6% YoY 10.4% QoQ
269
133.9% YoY 216.5% QoQ
41
-85.6% YoY -84.8% QoQ
2023 213
176.6% YoY 419.5% QoQ
54
-36.5% YoY -74.6% QoQ
48
-82.2% YoY -11.1% QoQ
125
204.9% YoY 160.4% QoQ
2024 60
-71.8% YoY -52.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Vericel MACI search interestLast update: February 09 2024 11:27:18.
Correlation coefficient between keyword and revenue is -0.92
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 11:27:22.

The average 5 years interest of Vericel MACI was 7.85 per week.
The last year interest of Vericel MACI compared to the last 5 years has changed by 3.44%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 112.01%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Vericel Epicel to provide analysis

Correlation between past revenue and Vericel Epicel search interest

There is not enough data for Vericel Epicel to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Vericel Epicel to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Vericel NexoBrid to provide analysis

Correlation between past revenue and Vericel NexoBrid search interest

There is not enough data for Vericel NexoBrid to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Vericel NexoBrid to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Vericel burn care to provide analysis

Correlation between past revenue and Vericel burn care search interest

There is not enough data for Vericel burn care to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Vericel burn care to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Vericel sports medicine to provide analysis

Correlation between past revenue and Vericel sports medicine search interest

There is not enough data for Vericel sports medicine to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Vericel sports medicine to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Vericel headquarters to provide analysis

Correlation between past revenue and Vericel headquarters search interest

There is not enough data for Vericel headquarters to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Vericel headquarters to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Vericel contact to provide analysis

Correlation between past revenue and Vericel contact search interest

There is not enough data for Vericel contact to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Vericel contact to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for VCEL
Earnings date: 2024-02-22 After close
Company name: Vericel Corp
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-08T11:12:47Z

Analyst Upgrades
HC Wainwright & Co. Maintains Buy on Vericel, Raises Price Target to $70

2026-05-07T11:45:00Z

GlobeNewswire
Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance

2026-04-23T12:30:00Z

GlobeNewswire
Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026

2026-04-15T15:42:10Z

Analyst Upgrades
Truist Securities Maintains Buy on Vericel, Lowers Price Target to $42

2026-04-06T13:10:00-04:00

PR Newswire
Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines

2026-04-02T19:26:11Z

GlobeNewswire
MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million

2026-04-02T18:40:00Z

GlobeNewswire
Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid

2026-03-04T13:00:00Z

GlobeNewswire
Vericel Announces FDA Approval of New State-of-the-Art Advanced Therapy Manufacturing Facility

2026-03-03T13:30:00Z

GlobeNewswire
Vericel to Present at Multiple Upcoming Investor Conferences

2026-02-27T16:11:50Z

Analyst Upgrades
HC Wainwright & Co. Maintains Buy on Vericel, Raises Price Target to $64

2026-02-26T12:55:00Z

GlobeNewswire
Vericel Reports Fourth Quarter and Full-Year 2025 Financial Results

2026-02-12T13:30:00Z

GlobeNewswire
Vericel to Report Fourth-Quarter and Full-Year 2025 Financial Results on February 26, 2026

2026-01-13T14:00:00Z

GlobeNewswire
Vericel Announces Preliminary 2025 Financial Results and Business Updates

2026-01-06T13:30:00Z

GlobeNewswire
Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026

2025-12-18T16:10:48Z

Analyst Upgrades
Truist Securities Maintains Buy on Vericel, Lowers Price Target to $45